November 2009
Hem/Onc Today;11/10/2009, Vol. 10 Issue 21, p40
This section describes several medical devices and services, such as KinAffinity from Kinaxo, imatinib of the Prix Galien USA which was awarded for best pharmaceutical product by the Novartis, and the fentanyl buccal soluble film, Onsolis, from Meda.


Related Articles

  • European Patent Granted for Chemical Proteomics Applications.  // International Labmate;2011, Vol. 36 Issue 5, p23 

    The article reports that the European Patent Office has granted Kinaxo Biotechnologies a patent on chemical proteomics applications.

  • Financings Roundup.  // BioWorld Today;2/10/2011, Vol. 22 Issue 28, p3 

    The article reports on the acquisition by Evotec AG of all shares in Kinaxo Biotechnologies GmbH for 12 million Euros.

  • Kinaxo Biotechnologies extends collaboration with Roche.  // PharmaWatch: Biotechnology;Mar2010, Vol. 9 Issue 3, p16 

    The article reports on the extended agreement between Kinaxo Biotechnologies GmbH and Roche Diagnostics AG under which Kinaxo will apply its PhosphoScout phosphoproteomics technology to support therapeutic approaches currently under development at Roche.

  • EVOTEC ACQUIRES KINAXO EXPANDING DRUG DISCOVERY PLATFORM.  // Worldwide Biotech;Mar2011, Vol. 23 Issue 3, p5 

    The article provides information on the takeover of drug company Kinaxo Biotechnologies GmbH by Evotech AG, Hamburg, Germany, to strengthen Evotech's leadership in pharmaceutical and biotechnology. It lists Kinaxo's capabilities which include cellular target profiling, kinaffinity and...

  • Other News To Note.  // BioWorld Today;1/6/2011, Vol. 22 Issue 4, p2 

    This section offers news briefs concerning the biotechnology industry in the U.S. ArGen-X BV entered into alliance with Eli Lilly and Co. to generate human monoclonal antibody (mAb) candidates that act on diverse functional sites on Lilly targets. ImmunGene Inc. will collaborate with Cephalon...

  • Financings Roundup.  // BioWorld Today;11/23/2009, Vol. 20 Issue 226, p5 

    The article reports that a new financing round has been closed by Kinaxo Biotechnologies GmbH. The financing round gave the company two new investors, Leifina and Commit Invest. The company also has a new member in its advisory board, Jürgen Schumacher.

  • Kinaxo Extends Collaboration with Takeda. Astles, Gwyneth // LabAsia;2011, Vol. 18 Issue 2, p2 

    The article reports that Kinaxo Biotechnologies GmbH has extended its collaboration with Takeda Pharmaceutical Co. Ltd. to apply its phosphoproteomics technology in drug research and development.

  • Kinaxo in finals of German biotech competition.  // Pharmaceutical Technology Europe;Apr2008, Vol. 20 Issue 4, p68 

    The article reports on the final round of "BioPharma ― The Strategy Competition for Medicine of the Future" that has been reached by the Kinaxo Biotechnologies in Germany. The author stated that the competition is an initiative of the German federal government which aims to identify...

  • Collaborations Between Biotech And Pharmaceutical Companies: Oct. 1 - Nov. 24, 2009.  // BioWorld Insight;11/30/2009, Vol. 17 Issue 48, p6 

    The article presents the biotechnology and pharmaceutical companies collaborations between October 1, 2009 to November 24, 2009. AC Immune SA collaborated with Bayer Schering Pharma AG for diagnostic imaging of Alzheimer's disease. PepTcell Ltd. subsidiary Biocopea Ltd. partners with Sosei Group...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics